Managing GLP-1 Side Effects

Most people who stop a GLP-1 medication early stop because of how it made them feel in the first few weeks, not because it did not work. A good deal of that is manageable, and some of it is predictable enough to plan around.

Why the gut is where this shows up

GLP-1 receptor agonists slow gastric emptying. Food stays in the stomach longer, which contributes to the sensation of fullness that is central to how the medication acts on appetite. The same mechanism is responsible for most of the unwanted effects: nausea, early satiety, reflux, bloating and constipation are downstream of the same slowing. There are GLP-1 receptors in the brainstem too, in areas involved in nausea and vomiting. So the effect is not purely mechanical. Understanding this is useful because it explains why the standard advice works. Smaller portions help because the stomach is emptying slowly. Eating more slowly helps for the same reason. Fatty and fried food is harder because fat already slows gastric emptying on its own.

What titration is doing

Every approved product in this class comes with a stepwise dose escalation schedule, and it exists for tolerability rather than for anything else. Receptor systems adapt with exposure. Starting low and increasing slowly gives that adaptation time to occur. The practical consequence is that the worst days tend to be the first several after starting, and the first several after each increase. If you know that, you can plan the increase for a week when you are not travelling or presenting at a conference. Titration is not a race. Your provider can hold you at a dose longer than the standard schedule, or step back to the previous one. A dose you can actually stay on is more useful than a higher one you abandon.

What generally helps

Eat less at a sitting, more often. A large meal on a slowly emptying stomach is the most reliable way to feel unwell. Prioritise protein. Reduced intake plus reduced appetite makes it easy to under-eat protein badly, and lean mass is what you lose when that happens. Aim for protein at every meal rather than concentrating it in one. Drink through the day, not with meals. Volume in the stomach at mealtimes makes fullness worse. Dehydration is also a common contributor to the headaches and fatigue people report. Manage constipation early. Reduced food volume, reduced fibre and slowed transit make it very common. Fibre, fluid and movement first; ask your provider before adding anything pharmacological. Avoid the triggers you already know about. Fried food, large volumes of fat, and alcohol are the three that come up most.

What warrants contacting your provider

Some symptoms are not part of the adjustment period.

• Severe abdominal pain, particularly pain radiating to the back, with or without vomiting.

Pancreatitis is described in the prescribing information for this class and is a reason to stop and be assessed.

• Persistent vomiting or an inability to keep fluids down. Dehydration on top of these

medications has been associated with acute kidney injury.

• Right upper abdominal pain, fever, or yellowing of the skin or eyes. Gallbladder disease is

described in this class, and rapid weight reduction independently raises gallstone risk.

• Signs of low blood sugar — shakiness, sweating, confusion — particularly if you also take

insulin or a sulfonylurea, where dose adjustment may be needed.

• Vision changes, if you have diabetic retinopathy.
• A neck lump, hoarseness or difficulty swallowing, given the thyroid C-cell findings described

for this class. None of this is a reason not to take a medication your provider has determined is appropriate. It is a reason to know what you are looking for.

Planning around a surgery or procedure

Delayed gastric emptying matters for anaesthesia, because a stomach that is not empty when it is assumed to be empty is an aspiration risk. Anaesthesia guidance on GLP-1 medications has been evolving. Tell any surgeon, anaesthetist or endoscopist that you are on one, well ahead of the procedure, and tell your prescribing provider that the procedure is scheduled.

When it does not settle

Adjustment for most people is measured in weeks. If it is not settling, that is information rather than a failure of willpower. Options your provider may consider include holding the dose, stepping back, changing the medication within the class, or concluding that this class is not the right approach for you. All of those are legitimate outcomes, and all of them are better than quietly stopping and not saying so.